Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema. | Clin Rev Allergy Immunol | 2021 | 33956309 | PubTator, text mining | PubMed |
| A modified clot-based assay to measure negatively charged procoagulant phospholipids. | Sci Rep | 2021 | 33927323 | PubTator, text mining | PubMed |
| Proton Bridging in Catalysis by and Inhibition of Serine Proteases of the Blood Cascade System. | Life (Basel) | 2021 | 33925363 | PubTator, text mining | PubMed |
| Confocal Blood Flow Videomicroscopy of Thrombus Formation over Human Arteries and Local Targeting of P2X7. | Int J Mol Sci | 2021 | 33920051 | PubTator, text mining | PubMed |
| A History of Preterm Delivery Is Associated with Aberrant Postpartal MicroRNA Expression Profiles in Mothers with an Absence of Other Pregnancy-Related Complications. | Int J Mol Sci | 2021 | 33919834 | PubTator, text mining | PubMed |
| Overview of the Therapeutic Potential of Aptamers Targeting Coagulation Factors. | Int J Mol Sci | 2021 | 33918821 | PubTator, text mining | PubMed |
| Evaluation of the hemostatic capacity of methylene blue-treated liquid (not frozen) plasma stored up 14 days at 2° to 6°C. | Transfusion | 2021 | 33913163 | PubTator, text mining | PubMed |
| C8B in Complement and Coagulation Cascades Signaling Pathway is a predictor for Survival in HBV-Related Hepatocellular Carcinoma Patients. | Cancer Manag Res | 2021 | 33911900 | PubTator, text mining | PubMed |
| Establishment and evaluation of a rat model of extracorporeal membrane oxygenation (ECMO) thrombosis using a 3D-printed mock-oxygenator. | J Transl Med | 2021 | 33910585 | PubTator, text mining | PubMed |
| [Hereditary coagulation factor XIII deficiency: three cases report and literaure review]. | Zhonghua Xue Ye Xue Za Zhi | 2021 | 33910314 | PubTator, text mining | PubMed |
| [Congenital factor Ⅺ deficiency: a retrospective analysis of 80 cases]. | Zhonghua Xue Ye Xue Za Zhi | 2021 | 33910305 | PubTator, text mining | PubMed |
| [How I diagnose and treat acquired hemophilia A]. | Zhonghua Xue Ye Xue Za Zhi | 2021 | 33910303 | PubTator, text mining | PubMed |
| Highlights from the American society of hematology conference 2020. | J Thromb Thrombolysis | 2021 | 33900522 | PubTator, text mining | PubMed |
| Key drug-targeting genes in pancreatic ductal adenocarcinoma. | Genes Cancer | 2021 | 33884102 | PubTator, text mining | PubMed |
| An Integrated Approach of the Potential Underlying Molecular Mechanistic Paradigms of SARS-CoV-2-Mediated Coagulopathy. | Indian J Clin Biochem | 2021 | 33875909 | PubTator, text mining | PubMed |
| Acquired haemophilia in patients with malignant disease: A case report. | World J Clin Cases | 2021 | 33869621 | PubTator, text mining | PubMed |
| Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity. | Front Immunol | 2021 | 33859644 | PubTator, text mining | PubMed |
| [Consensus of Chinese expert on the diagnosis and treatment of rare bleeding disorders (version 2021)]. | Zhonghua Xue Ye Xue Za Zhi | 2021 | 33858037 | PubTator, text mining | PubMed |
| COVID-19: imbalance of multiple systems during infection and importance of therapeutic choice and dosing of cardiac and anti-coagulant therapies. | Mol Biol Rep | 2021 | 33837899 | PubTator, text mining | PubMed |
| Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study. | J Am Heart Assoc | 2021 | 33834859 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=52